Cancer
Conditions
Brief summary
To collect information about how patients in the pain management clinic use cannabis/CBD, including how often it is used, why it is used (for example, to manage pain or other symptoms), and where patients get their information on cannabis/CBD for pain management
Detailed description
Objectives Primary Objective: The primary objective of this study is to investigate the prevalence of current and prior cannabis and/or CBD use in cancer patients who present to the pain management clinic at MDACC. Secondary Objectives: The secondary objective is to investigate the reason for cannabis/CBD use (e.g. pain, neuropsychiatric symptoms, recreational or other use), degree of symptom improvement with use, frequency of use, methods of use (e.g. inhaled vs. ingested), sources of information on cannabis/CBD, and patient interest in learning more from their physicians about cannabis/CBD for cancer pain.
Interventions
BEHAVIORALCannabis (Marijuana)
The level of interest in learning more about cannabis for cancer pain, we can better facilitate a patient-centered approach to comprehensive treatment plans through patient education.
BEHAVIORALCannabidiol (CBD)
The level of interest in learning more about cannabis for cancer pain, we can better facilitate a patient-centered approach to comprehensive treatment plans through patient education
Sponsors
M.D. Anderson Cancer Center
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1. Age 18 years or older 2. Cancer patients who present to the MD Anderson Pain Medicine Clinic as a new patient or consult 3. Willing to give informed consent 4. Willing to complete the survey
Exclusion criteria
1. Refusal of informed consent 2. Refusal to complete the survey 3. Patients who previously completed the survey 4. Patients who opt-out or change their mind after agreeing to participate 5. Already an established patient at MDACC Pain Medicine Clinic 6. Patients scheduled to see Dr Abdi (PI).
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Cannabis (Marijuana) and CBD (Cannabidiol for Cancer Pain Survey | through study completion; an average of 1 year. | Score scale ranges from 1-5, Extremely interested(1),Not Interested (5) |
Countries
United States
Contacts
PRINCIPAL_INVESTIGATORSalahadin Abdi, MD,PHD
M.D. Anderson Cancer Center
Outcome results
None listed